XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.3
Segments and Disaggregated Revenue (Tables)
 9 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
Schedule of Segments and Disaggregated Revenue

 

 

Construction

 


Medical

Corporate and support



Consolidated

 


Nine Months Ended September 30, 2024
















Revenue 
$ 3,932,592

$ —

$ —

$ 3,932,592

Cost of revenue



3,618,031


—


—


3,618,031

Operating expenses

113,656


95,972


5,126,860


5,336,488

Operating loss

200,905

(95,972 )

(5,126,860 )

(5,021,927 )

Other expense

(275,321 )

—


(7,843,826 )

(8,119,147 )

Loss before income taxes

(74,416 )

(95,972 )

(12,970,686 )

(13,141,074 )

Common stock deemed dividend

—


—


(1,146,594 )

(1,146,594 )

Income from discontinued operations

—


—


2,776,013


2,776,013

Net loss attributable to common stockholders of Safe & Green Holdings Corp.
$ (74,416 )
$ (95,972 )
$ (11,341,267 )
$ (11,511,655 )



















Total assets
$ 5,778,540

$ 1,406
$ 4,019,316

$ 9,799,262

Depreciation and amortization
$
 194,803

$ —

$ 5,317

$ 200,120

Capital expenditures
$ 8,007

$ —

$ —

$ 8,007






















Construction




Medical



Corporate and support




Consolidated



Nine Months Ended September 30, 2023

 



 








 






Revenue
$ 14,566,351

$ —

$ —

$ 14,566,351

Cost of revenue



15,138,225


—


—


15,138,225

Operating expenses

68,384


139,135


9,265,290


9,472,809

Operating loss

(640,258 )

(139,135 )

(9,265,290 )

(10,044,683 )

Other (expense) income

(56,796 )

—

34,346

(22,450 )

Loss before income taxes

 


(697,054

 )

(139,135 )

 

(9,230,944

 )

 

(10,067,133 )

Net income attributable to non-controlling interest

 


—

 



—


—


—

Loss from discontinued operations

—


—


(2,615,965 )

(2,615,965 )

Net loss attributable to common stockholders of Safe & Green Holdings Corp.
$ (697,054 )
$ (139,135 )
$ (11,846,909 )
$ (12,683,098 )



















Total assets
$ 7,111,643

$ 4,581
$
 6,565,385

$
 13,681,609

Depreciation and amortization
$ 146,917

$ —

$ 1,391,743

$ 1,538,660

Capital expenditures
$ —

$ —

$ 530,055

$ 530,055

 

 

 

Construction

 


Medical

Corporate and support

 


Consolidated

 


Three Months Ended September 30, 2024
















Revenue 
$ 1,753,223

$ —

$ —

$ 1,753,223

Cost of revenue



1,878,799


—


—


1,878,799

Operating expenses

21,842


10,012


2,083,655


2,115,509

Operating loss

(147,418 )

(10,012 )

(2,083,655 )

(2,241,085 )

Other expense

(87,413 )

—


(1,387,607 )

(1,475,020 )

Loss before income taxes

(234,831 )

(10,012 )

(3,471,262 )

(3,716,105 )

Common stock deemed dividend

—


—


—

—

Net income attributable to non-controlling interest

—


—


—


—

Net loss attributable to common stockholders of Safe & Green Holdings Corp.
$ (234,831 )
$ (10,012 )
$ (3,471,262 )
$ (3,716,105 )



















Total assets
$ 5,778,540

$ 1,406
$ 4,019,316

$ 9,799,262

Depreciation and amortization
$
 113,256

$ —

$ 1,830

$ 115,086

Capital expenditures
$ 1,136

$ —

$ —

$ 1,136






















Construction




Medical



Corporate and support




Consolidated



Three Months Ended September 30, 2023 

 



 








 






Revenue
$ 3,965,361

$ —

$ —

$ 3,965,361

Cost of revenue



4,501,393


—


—


4,501,393

Operating expenses

(108,603 )

138,240


1,825,464


1,855,101

Operating loss

(427,429 )

(138,240 )

(1,825,464 )

(2,391,133 )

Other (expense) income 

(308,988 )

—

15,530

(293,458 )

Loss before income taxes

 


(736,417

 )

(138,240 )

 

(1,809,934

 )

 

(2,684,591 )

Net income attributable to non-controlling interest

 


—

 



—


—


—

Loss from discontinued operations

—


—


(923,543 )

(923,543 )

Net loss attributable to common stockholders of Safe & Green Holdings Corp.
$ (736,417 )
$ (138,240 )
$ (2,733,477 )
$ (3,608,134 )



















Total assets

7,111,643


4,581


6,565,385


13,681,609

Depreciation and amortization
$ 53,147

$ —

$ 432,707

$ 485,854

Capital expenditures
$ —

$ —

$ 526,252

$ 526,252